XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT REPORTING (Tables)
 6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENTS

The following table presents certain information regarding the Company’s segments as of and for the three months ended June 30, 2024 and 2023 (in thousands):

 

2024

 

   CVD
Equipment		   SDC  

CVD

Materials

   Eliminations   Corporate   Consolidated 
Assets  $29,368   $4,310   $222   $(55)  $-   $33,845 
                               
Revenue  $4,107   $2,315   $55   $(132)  $-   $6,345 
Operating (loss) income   (729)   714    (45)   (8)   (830)   (898)
Pretax (loss) income   (743)   714    (45)   (8)   (679)   (761)
Depreciation and amortization  $141   $13   $-   $-   $-   $154 
Purchase of property, plant & equipment  $101   $4   $-   $-   $-   $105 

 

2023

 

  

CVD

Equipment

   SDC  

CVD

Materials

   Eliminations   Corporate   Consolidated 
Assets  $32,139   $4,189   $483   $(28)  $-   $36,783 
                               
Revenue  $3,134   $1,795   $342   $(202)  $-   $5,069 
Operating (loss) income   (445)   363    *(224)   (28)   (898)   (1,232)
Pretax (loss) income   (445)   364    *(203)   (28)   (791)   (1,103)
Depreciation and amortization  $136   $12   $79   $-   $-   $227 
Purchase of property, plant & equipment  $78   $-   $-   $-   $-   $78 

 

*Includes loss on sale of Tantaline of $0.2 million and impairment charge related to MesoScribe fixed assets of $0.1 million.

 

 

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

NOTE 10: SEGMENT REPORTING (continued)

 

The following table presents certain information regarding the Company’s segments as of and for the six months ended June 30, 2024 and 2023 (in thousands):

 

2024

 

   CVD
Equipment		   SDC  

CVD

Materials

   Eliminations   Corporate   Consolidated 
                         
Revenue  $7,054   $4,246   $114   $(147)  $-   $11,267 
Operating (loss) income   (2,173)   1,346    (71)   10    (1,638)   (2,526)
Pretax (loss)
Income		   (2,188)   1,346    (71)   10    (1,330)   (2,233)
Depreciation and amortization  $283   $24   $-   $-   $-   $307 
Purchase of property, plant & equipment
  $178   $4   $-   $-   $-   $182 

 

2023

 

   CVD
Equipment		   SDC  

CVD

Materials

   Eliminations   Corporate   Consolidated 
                         
Revenue  $8,979   $4,107   $1,009   $(331)  $-   $13,764 
Operating (loss) income   (267)   994    (143)*   (28)   (1,976)   (1,420)
Pretax (loss)
Income		   (265)   996    (95)*   (28)   (1750)   (1,142)
Depreciation and amortization  $267   $24   $101   $-   $-   $392 
Purchase of property, plant & equipment  $215   $10   $-   $-   $-   $225 

 

*Includes loss on sale of Tantaline of $0.2 million and impairment charge related to MesoScribe fixed assets of $0.1 million.